AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06334796 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Virtual Assistant
Description: Stage 1 focused on safety, using only medical information from clinical records for the virtual assistant. In Stage 2, which evaluated accuracy, participants interacted with the virtual assistant post-medical stabilization. Additionally, participants also provided initial symptom details for Chat-GPT input. Nine neurologists specializing in emergency participated in the study. In Stage 1, they assessed the virtual assistant's performance using clinical history information. In Stage 2, they analyzed the results from participant interactions with the assistant and performed a comparative evaluation of Chat-GPT. The virtual assistant functioned as a chatbot on WhatsApp and Telegram, using Spanish and incorporating advanced algorithms, decision trees, and large language models for interaction. For comparison, we utilized Chat-GPT versions 3.5 and 4, employing two prompt types in natural Spanish: one incorporating clinical record data and the other based on participant narratives.
Study NCT05600517 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fluoride
Description: a patient-centered education on diet, oral hygiene and fluoridated toothpaste 5000ppm with check up´s and topical fluoride application (varnish) every second month.
Study NCT01738412 — intervention group
Intervention type: DEVICE
Intervention: Neurokeeper stroke detector
Description: Monitoring stroke patients
Study NCT06308211 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MOTOR IMAGERY+MIRROR THERAPY+ROUTINE PHYSICAL THERAPY
Description: Subjects will be instructed to watch the video provided and recorded by investigator.In next step participants will be asked to close the eyes to focus and then to imagine how they are doing task they had previously observed 10 times.Participants will be than instructed to carry out the task in verbal commands given whenever necessary.The unaffected limb will be placed in front of the mirror so that the reflected illusion of the limb would be hallucinated to represent the affected limb and routine physical therapy includes passive and active assisted range of motion for the upper and lower extremity including the shoulder, forearm, wrist, hip, knee and ankle will be given (10 - 15 repititions).
Study NCT06308211 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MOTOR RELEARNING PROGRAM+ROUTINE PHYSICAL THERAPY
Description: Motor relearning consists of five components including analysis of task, practice of missing components, practice of task and transference of training. Patient will be asked to practice task in both sitting and standing~* supine to side-lying to sitting~* looking up at ceiling (ensure that centre of body mass does not move back when head is tilted back)~* without moving one's feet, turning to gaze over each other's shoulders and scanning the surroundings for specific items, reaching motions in multiple directions while moving the head and trunk, scooting in bed, altering the base of support (standing with your feet together, in tandem, with one foot on a step, or on one leg)~* squatting to pick up an object and cross over stepping and routine physical therapy includes Passive and active assisted range of motion for the upper and lower extremity including the shoulder, forearm, wrist, hip, knee and ankle will be given (10 - 15 repititions).
Study NCT06638359 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: moderate exercise
Description: moderate exercise for 47 minutes
Study NCT06638359 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: moderate exercise
Description: moderate exercise for 47 minutes
Study NCT06638359 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: interval exercise
Description: interval exercise for 28 minutes
Study NCT06638359 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: interval exercise
Description: interval exercise for 28 minutes
Study NCT06638359 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Control (placebo) group
Description: without exercise
Study NCT06638359 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control (placebo) group
Description: without exercise
Study NCT06640673 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Hd-EEG
Description: Subjects undergo a clinical and neuropsychological assesment, then a Hd-EEG both during resting state and execution of tasks, and structural Magnetic Resonance Imaging
Study NCT05236023 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Zero separation and couplet care
Description: The essence of the intervention is that treatment-requiring mother-infant dyads are admitted together and receives couplet care provided by neonatal nurses.~The nurses will be educated for the intervention by participating in a two-day course about postpartum observations, treatment and care; and participate in education about family-centred care and family-focused nursing.
Study NCT05148338 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Comprehensive risk factor treatment
Description: 1. Apnea screening with Home Sleep Apnea Test. Referral to sleep physician if apnea-hypopnea index (AHI) is greater than 5~2. Weight management counseling by dietician if body mass index (BMI) is above 27 kg/m2~3. Physical activity program under supervision of physiotherapist at a specialized cardiac rehabilitation centre if BMI is over 27 or if there are complaints during exercise~4. Smoking cessation at specialized outpatient clinic~5. Blood pressure control, lipid management, glycaemic control, alcohol intake reduction by specialized AF nurse~6. Motivation and education through a digital health platform
Study NCT05148338 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: Standard usual care: Treatment by cardiologist conform existing guidelines
Study NCT06126172 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Multiparametric magnetic resonance imaging (mpMRI)
Description: Detecting and localizing prostate cancers and using radiomics extracted from prostate mpMRI for risk stratification patients of histological aggressiveness as well as to predict very early recurrence of PCA patients within 6 months after radical prostatectomy.
Study NCT06637293 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DeepECG plateform diagnosis & recommendations
Description: EchoNeXT\& ECG-AI algorithm
Study NCT06170892 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kangaroo method
Description: The newborns were placed in the kangaroo position in a single session, and the variables were identified before, during and after the application of the technique.
Study NCT05859685 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental
Description: Manual therapy techniques:~* Talar dorsal sliding technique. Dorsal mobilization of the talus, with the patient in the supine position and ankle dorsiflexion, without pain or discomfort. The physiotherapist will exercise an anteroposterior mobilization of the talus, with a dorsal glide~* Mulligan movement mobilization technique: The patient will be in a standing position, with the ankle to be treated forward. You will be given an aid or support in the upper extremity to maintain stability.
Study NCT05859685 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: The patients included in the control group underwent the same techniques as those indicated for the experimental group, but without sliding or placing joint tension. The periodicity and times of administration will be the same
Study NCT06638255 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sequence A involves administering Low PEEP for 12 hours, followed by High PEEP for 12 hours.
Description: Patients will first receive the Low PEEP protocol for 12 hours, followed by the High PEEP protocol for 12 hours. This sequence is randomized and part of a crossover trial design to assess the effects of both PEEP strategies.~Description: Patients will first receive the High or LOW PEEP protocol for 12 hours, followed by the Low or HIGH PEEP protocol for 12 hours. This sequence is randomized and part of a crossover trial design to assess the effects of both PEEP strategies.
Study NCT06638255 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sequence B involves setting High PEEP for 12 hours, followed by Low PEEP for 12 hours.
Description: Sequence B involves setting High PEEP for 12 hours, followed by Low PEEP for 12 hours.
Study NCT06642740 — intervention group
Intervention type: OTHER
Intervention: Platelet count
Description: divide into two groups based on platelet count
Study NCT04254289 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Usual care
Study NCT04254289 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-based exercise program
Description: Home-based program determined by exercise physiologist
Study NCT06391840 — intervention group
Intervention type: OTHER
Intervention: Airway ultrasound
Description: Pre-operative airway ultrasound
Study NCT04799327 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR20004
Description: SHR20004：low dose
Study NCT05297396 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Slow Tapering of Chronic Opioid Therapy
Description: Clinically prescribed daily opioids reduced by no more than 10 morphine milligram equivalent per day (MMED) each month for 12 months
Study NCT05824845 — intervention group
Intervention type: PROCEDURE
Intervention: Hip/Knee Replacement
Description: Hip/Knee Replacement
Study NCT05671185 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation
Description: rTMS using Magstim TMS system is delivered at the left dorsolateral prefrontal cortex
Study NCT05671185 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Repetitive Transcranial Magnetic Stimulation
Description: rTMS using Magstim TMS system is delivered at the left dorsolateral prefrontal cortex
Study NCT06111053 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ENDS
Description: Participants in active comparator groups that include ENDS will receive 6-weeks worth of ENDS supplies.
Study NCT06111053 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CI
Description: Participants in active comparator groups will receive incentives that vary based on participant abstinence from smoking, measured by a carbon monoxide breath sample.
Study NCT06111053 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: No ENDS
Description: Participants in active comparator groups labeled No ENDS will only receive information about the comparative risk of ENDS relative to combustible cigarettes.
Study NCT06111053 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NI
Description: Participants in active comparator groups labeled NI will receive compensation for each breath sample provided throughout the study, with no variation.
Study NCT04799327 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR20004
Description: SHR20004: medium dose
Study NCT04799327 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR20004
Description: SHR20004: high dose
Study NCT04799327 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Placebo
Study NCT06640660 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mindlenses Professional
Description: MindLenses professional's device combines the prismatic adaptation (PA) procedure with the administration of serious games (SG) for cognitive training using a tablet
Study NCT06640660 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional rehabilitation
Description: Conventional rehabilition consists in computerized exercises focused on the main cognitive domains
Study NCT06463769 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 8 week predominantly plant-based New Nordic LPF-diet program
Description: An 8-week patient-centered dietary intervention program will be implemented to maintain a predominantly plant-based New Nordic LPF-Diet.
Study NCT06463769 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: maintenance of the predominantly plant-based New Nordic LPF-diet
Description: Follow-up of long-term adherence to the diet at one and six months after completion of the intervention program.
Study NCT05193552 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hizentra
Description: subjects level of immunoglobulin replacement therapy will be adjusted for bioavailability as per manufacturer's instructions
Study NCT06637280 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High - flow nasal cannula
Description: High flow nasal cannula (HFNC), a device first introduced in neonates and pediatric care, is currently used in a wide range of indications in adult respiratory and critical care medicine (5-7). It is a relatively new method in bronchoscopy with several notable theoretical advantages over low flow oxygen via conventional nasal cannula (CNC):~* High flow up to 60 liters per minute ensures a more stable FiO2 and better matches the increased patient's inspiratory flow~* High flow generates a small positive expiratory airway pressure (up to 5 cm H2O) which could stabilize the upper airways during sedation and have a beneficial effect in the lower airways~* High flow reduces dead space in the upper airways and increases alveolar ventilation.
Study NCT06637280 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard nasal cannula
Description: Standard method for supplementing oxygen during EBUS bronchoscopy
Study NCT04805593 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WaveLight EX500 excimer laser system
Description: FDA approved stationary scanning-spot excimer laser system used during refractive surgery for the treatment of myopia, myopic astigmatism, hyperopia, hyperopic astigmatism, and mixed astigmatism. For this clinical study, the Wavefront Optimized (WFO) Ablation profile of the WaveLight EX500 excimer laser system will be used for bilateral LASIK treatment of hyperopia with and without astigmatism.
Study NCT05681416 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Panel sequencing, whole exome sequencing, whole genome sequencing
Description: Besides the mutation positive men (group 2), all will receive multigene panel analysis in a patient care setting and if negative, whole exome sequencing (WES), whole genome sequencing and transcriptome analyses. In PCA-affected men (group 3), additional mutational analysis will be performed on formalin-fixed paraffin embedded (FFPE) - and fresh frozen (FF) tumor tissue from biobanked radical prostatectomy specimens using FFPE panel analysis (like TruSightOncology 500) or WES if FF samples are available.
Study NCT05058131 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Dietary fibre
Description: Dietary fibre as a powder, 24 g per day for 6 weeks
Study NCT05058131 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo compound
Description: Maltodextrin powder, 24 g per day for 6 weeks
Study NCT05853562 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: structured vestibular rehabilitation program
Description: The structured Vestibular rehabilitation protocol consisted of a structured vestibular rehabilitation program that included vestibular adaptation exercises, oculomotor exercises, static and dynamic balance exercises, and posture exercises.
Study NCT05853562 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: structured vestibular rehabilitation program
Description: The structured Vestibular rehabilitation protocol consisted of a structured vestibular rehabilitation program that included vestibular adaptation exercises, oculomotor exercises, static and dynamic balance exercises, and posture exercises.
Study NCT06635915 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Postoperative ultrasound
Description: Ultrasound will be performed to both groups in the postoperative period to assess the normoposition or the absence of nasogastric tube.
Study NCT06635915 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Postoperative ultrasound
Description: Ultrasound will be performed to both groups in the postoperative period to assess the normoposition or the absence of nasogastric tube.
Study NCT05255055 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical Therapy
Description: A manual therapy protocol and a therapeutic exercise protocol
Study NCT05425238 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood flow restriction
Description: strengthening protocol but with Blood flow restriction technique~.Standard BFR Application: a standard pressure (used for all patients) for e.g. 180~mmHg; a pressure relative to the patient's systolic blood pressure, for e.g. 1.2 - or 1.5-fold greater than systolic blood pressure.40% cuff pressure as percentage of LOP.(4) And performing BFR-RE with low load exercises. So 30% of 1 RPM would be enough 4 times a week for 6 week
Study NCT05425238 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physical therapy
Description: Resistance exercise 75 repetitions across four sets of exercises, with30 repetitions in the first set and 15 repetitions in each subsequent set. 4 times a week for 6
Study NCT06535490 — intervention group
Intervention type: PROCEDURE
Intervention: EUS-FNA
Description: Puncture of pancreatic cystic lesion with a fine needle under EUS guidance
Study NCT06535490 — intervention group
Intervention type: DRUG
Intervention: ATBp
Description: Antibiotic prophylaxis consists of a single intravenous administration before or at the beginning of the procedure according to the common practices of each practitioner or unit
Study NCT05509088 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: high flow nasal cannula
Description: Patients in the intervention group receive oxygen through HFNC with a flow rate of set initially at 40 L / min, FiO2 adjusted to maintain SpO2 ≥ 92%, and will be humidified, heated to 34-37 °C, disconnection will be allowed only when ambulation is required, patients will be instructed to practice mouth closing throughout the HFNC therapy as much as possible
Study NCT04805593 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: LASIK
Description: Procedure that reshapes the front part of the eye (cornea) so that light traveling through it is properly focused on the back part of the eye (retina). The procedure will be performed using the WaveLight EX500 excimer laser system.
Study NCT06280989 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: kinesio taping
Description: Before treatment, all female participants will undergo an allergic test on the anterior surface of the elbow.~To ensure cleanliness, alcohol will be used to clean the areas to be evaluated before applying the tape. The H technique will be employed to apply KT over the lumbar region. Participants will be instructed to bend forwards from the waist, and two vertical strips will be applied. These strips will stretch the Golgi tendon organ on both sides of the spine from the top of the buttock cleft upwards to a mid-point, with less than 25% stretch .~Additionally, a horizontal strip will be attached across the left and right sacroiliac joints. This strip will be stretched to 50% of its maximum capacity,.
Study NCT06280989 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: myofascial release technique
Description: myofascial release technique will be applied from prone on lumbar paravertebral muscles by using the olecranon of the physical therapist for 3 minutes, thoracolumbar fascia by using cross-handed hold, with hands placed on the T12-L1 levels and on the sacrum for 5 minutes without repetition and quadratus lumborum by using elbow with low pressure obliquely towards the center of the column for 7 min.~Additionally, from supine on psoas muscle by transversal sliding of the psoas fascia. The therapist will place the hands laterally 3 cm from the umbilicus.
Study NCT04828239 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: laser acupuncture
Description: 400 mW, near-infrared, continuous wavelength, 810 nm. about 24J/cm2
Study NCT06564987 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 4% Articaine with 1:200,000 epinephrine
Description: Inferior Alveolar Nerve Block with 4% articaine
Study NCT06564987 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 2% lidocaine with 1:100,000 epinephrine
Description: Inferior Alveolar Nerve Block with 2% lidocaine
Study NCT06419881 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tele-drama therapy
Description: A 12-week tele-drama therapy group intervention integrating Playback Theater and Life Review Therapy
Study NCT06419881 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual Care
Description: This arm continued to receive the routine activities provided by Uniper Care
Study NCT05072379 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: colostomy self-care app
Description: The study will use mixed methods as the study design in which content analysis will be used to identify the content suited for the App based on interviews with participants. A systematic research and development process will be utilized to design the text, videos, and images in the App's simulations to provide accurate, consistent, and complete knowledge of the skills needed for colostomy self-care and contending with any potential emergency.
Study NCT04853121 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Tapered Implants
Description: Tapered Implants are placed in fresh socket via dynamic navigation
Study NCT04853121 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Straight Implants
Description: Straight Implants are placed in fresh socket via dynamic navigation
Study NCT05848817 — intervention group
Intervention type: DEVICE
Intervention: Contoura LASIK
Description: Subjects receiving Phorcides Planned Contoura LASIK
Study NCT06043011 — intervention group
Intervention type: OTHER
Intervention: Routine care as per site standard.
Description: Physician's choice according to patient's needs.